# Glyburide + Metformin

## GlucoMET 5/500mg(鋁箔/錫箔)

| TAH Drug Code      | [OGLUM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OGLUM                                                                                                                                                                                                                                                                 |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | As initial or 2nd-line therapy in the treatment of type 2 diabetes.                                                                                                                                                                                                                                                                   |
| Dosing             | Initial 0.5-1 TAB once daily, max 4 TAB (20 mg glyburide and 2000 mg metformin).                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Renal disease or renal dysfunction, CHF requiring pharmacologic treatment, acute or chronic metabolic acidosis, including diabetic ketoacidosis with or without coma. Treatment should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials.  |
| Adverse Effects    | GI disturbances, headache, abdominal pain, dizziness. Rarely, lactic acidosis. Endocrine metabolic: Cobalamin deficiency (7% ), Hypoglycemia Gastrointestinal: Abdominal pain (6.9% ), Diarrhea (17% ), Nausea and vomiting (7.6% ) Neurologic: Dizziness (5.5% ), Headache (8.9% ) Respiratory: Upper respiratory infection (17.3% ) |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/glyburide-and-metformin-drug-information)                                                                                                                                                                                                                                                |

